Department of Molecular and Medical Virology, Ruhr-Universität Bochum, Universitätsstr. 150, 44801 Bochum, Germany.
Vaccine. 2010 Apr 26;28(19):3273-7. doi: 10.1016/j.vaccine.2010.02.090. Epub 2010 Mar 4.
DNA electroporation is a powerful vaccine strategy that could be rapidly adapted to address emerging viruses. We therefore compared cellular and humoral immune responses in mice vaccinated with DNA expression plasmids encoding either the wildtype or a codon-optimized sequence of hemagglutinin from the novel swine origin H1N1 influenza virus. While expression of HA from the wildtype sequence was hardly detectable, the H1N1 hemagglutinin was well expressed from the codon-optimized sequence. Despite poor expression of the wildtype sequence, both plasmids induced similar levels of CD4(+) T-cell responses. However, CD8(+) T-cell and antibody responses were substantially higher after immunization with the codon-optimized DNA vaccine. Thus, efficient induction of immune effector mechanisms against HA of the novel H1N1 influenza virus requires codon-optimization of the DNA vaccines. Since DNA vaccines and several viral vector vaccines employ the same cellular RNA-Polymerase II dependent expression pathway, the poor expression levels from wildtype HA sequences might also limit the induction of immune effector mechanisms by such viral vector vaccines.
DNA 电穿孔是一种强大的疫苗策略,可以快速适应新出现的病毒。因此,我们比较了用编码新型猪源 H1N1 流感病毒野生型或密码子优化序列血凝素的 DNA 表达质粒免疫的小鼠的细胞和体液免疫应答。虽然野生型序列的 HA 表达几乎检测不到,但从密码子优化序列可以很好地表达 H1N1 血凝素。尽管野生型序列的表达不佳,但两种质粒都诱导了相似水平的 CD4(+) T 细胞反应。然而,用密码子优化的 DNA 疫苗免疫后,CD8(+) T 细胞和抗体反应显著增强。因此,新型 H1N1 流感病毒 HA 的有效诱导需要 DNA 疫苗的密码子优化。由于 DNA 疫苗和几种病毒载体疫苗采用相同的细胞 RNA 聚合酶 II 依赖性表达途径,野生型 HA 序列的低表达水平也可能限制此类病毒载体疫苗诱导免疫效应机制。